Application Value of Carcinoembryonic Antigen,Serum Prostate Specific Antigen and Carbohydrate Antigen 199 in the Early Diagnosis of Prostate Cancer
Objective To explore the application value of carcinoembryonic antigen(CEA),serum prostate specific antigen(PSA)and carbohydrate antigen 199(CA199)in the early diagnosis of prostate cancer.Methods 98 patients with early prostate cancer admitted to our hospital from April 2021 to April 2023 were selected as observation group,and 98 patients with benign prostate disease during the same period were selected as control group.The CEA,PSA and CA199 levels of both groups were detected by enzyme-linked immunosorbent assay to analyze the diagnostic value of CEA,PSA and CA199 levels for early prostate cancer.Results The CEA,CA199 and PSA levels of the observation group were higher than those of the control group(P<0.05).The sensitivity of combined detection of CEA,PSA,and CA199 in the diagnosis of early prostate cancer was significantly higher than that of PSA alone,and the specificity was significantly higher than that of CEA,CA199 and PSA alone(P<0.05).Conclusions The combined detection of CEA,PSA,and CA199 in the diagnosis of early prostate cancer has important clinical significance,and can provide reference for clinical diagnosis and prognosis assessment.
Carcinoembryonic antigenSerum prostate specific antigenCarbohydrate antigen 199Prostatic cancer